Search
Search Results
##search.searchResults.foundPlural##
-
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1880PDF: 929HTML: 1515 -
Is laboratory monitoring useful in DOACs management?
937PDF: 874HTML: 130 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1624PDF: 956HTML: 389 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3592PDF: 1453HTML: 2728 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1735PDF: 554MP4: 474Html: 309 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4440PDF: 1450HTML: 2202 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3091PDF: 1082HTML: 1989 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4420PDF: 1591HTML: 478 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1452PDF: 631Suppl. Files: 384HTML: 178 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3031PDF: 1073HTML: 5654 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4619PDF: 1549HTML: 8546 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4911PDF: 1621HTML: 2272Untitled: 271Untitled: 285Untitled: 305Untitled: 254Untitled: 272 -
RECENT ADVANCES IN THE 5Q- SYNDROME
3041PDF: 1919HTML: 3826Pellagatti Fig 1: 262Pellagatti Fig. 2: 249 -
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1417PDF: 798HTML: 417 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3830PDF: 1360HTML: 2174Fig.1: 253Fig. 2: 246 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3497PDF: 1564HTML: 4085 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7926PDF: 2509HTML: 2141Table 1.: 269Table 2.: 276Table 3.: 259Table 4.: 255 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2594HTML: 322PDF: 963 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4737PDF: 2022HTML: 18185 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1881PDF: 631HTML: 364 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4190PDF: 1225HTML: 2116Fig.1: 241Fig. 2: 132Table 1: 244Table2: 262Table 3: 237 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2272PDF: 646HTML: 1177 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3219PDF: 945HTML: 7312Kost Fig1: 225Kost Fig 2: 212Kost Fig3: 226Kost Fig 4: 238Kost Fig5: 233Kost fig 6: 216 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5471PDF: 1398HTML: 2879Cover letter: 243 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2480PDF: 1057HTML: 1670Fig 1: 231Tab I: 253Cover Letter: 252 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2313PDF: 1689HTML: 651 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1728PDF: 875HTML: 1281Figure 1: 211Figure 2: 223Figure 3: 223







